Rogers Corp (ROG)

Trade ROG now with
2/20/2019 4:14:08 PM Rogers Q4 EPS $1.31 Vs $0.37 Last Year
2/5/2019 1:02:08 AM Genentech Submits SBLA To FDA For Kadcyla
1/30/2019 1:01:24 AM Genentech To Discontinue Phase III CREAD 1 And 2 Clinical Studies Of Crenezumab In Early Alzheimer’s Disease
1/17/2019 1:02:44 AM FDA Accepts Genentech’s SBLA For Tecentriq Plus Chemotherapy
1/15/2019 10:03:59 AM Roche Announces Launch Of Its UPath Enterprise Software For Digital Pathology
11/27/2018 7:02:46 AM Roche Launches First IVD Pan-TRK Immunohistochemistry Assay
11/13/2018 1:13:05 AM Genentech Says FDA Granted Priority Review To Tecentriq In Combination With Abraxane
11/1/2018 4:36:32 PM Rogers Q3 EPS $1.06 Vs. $1.37 Year Ago
10/31/2018 4:32:50 PM Roche Diagnostics To Replace CoaguChek XS PT Test Strips
10/24/2018 1:15:21 PM Genentech Announces FDA Approval Of XOFLUZA For Influenza
10/22/2018 3:38:43 AM Genentech Announcespositive Results From Phase III IMpower130 Study Of Tecentriq Plus Chemotherapy
10/19/2018 11:43:59 AM FDA Approves Label Update For Genentech’s Rituxan In Two Rare Forms Of Vasculitis
10/15/2018 1:01:27 AM Genentech Announces Phase III KATHERINE Study Meets Primary Endpoint
10/10/2018 1:08:29 AM Genentech Says OCREVUS Data Will Be Presented At 34th Congress Of ECTRIMS
10/9/2018 1:01:48 AM Genentech To Present New Positive Data From Broad Cancer Immunotherapy Program And Across A Wide Range Of Cancers
10/3/2018 7:31:45 AM Genentech Announces New Data For Risdiplam In Spinal Muscular Atrophy At The World Muscle Society Congress
9/28/2018 5:03:18 PM FDA Approves Genentech's Xolair Prefilled Syringe Formulation
9/17/2018 4:30:53 PM Rogers Corp Appoints Michael Ludwig As CFO
9/6/2018 1:03:50 AM Genentech To Present New Data From Extensive Lung Cancer Program At 2018 WCLC
8/23/2018 7:01:32 AM Roche Gets FDA Approval For Cobas EGFR Mutation Test V2 As Companion Diagnostic With IRESSA